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Abstract
Endothelial dysfunction (ED) and low-grade inﬂammation (LGI) have a role in the development of CVD. The two studies reported here
explored the effects of dietary proteins and carbohydrates on markers of ED and LGI in overweight/obese individuals with untreated elevated
blood pressure. In the ﬁrst study, ﬁfty-two participants consumed a protein mix or maltodextrin (3× 20 g/d) for 4 weeks. Fasting levels and
12 h postprandial responses of markers of ED (soluble intercellular adhesion molecule 1 (sICAM), soluble vascular cell adhesion molecule 1
(sVCAM), soluble endothelial selectin and von Willebrand factor) and markers of LGI (serum amyloid A, C-reactive protein and sICAM) were
evaluated before and after intervention. Biomarkers were also combined into mean Z-scores of ED and LGI. The second study compared
4 h postprandial responses of ED and LGI markers in forty-eight participants after ingestion of 0·6 g/kg pea protein, milk protein and egg-white
protein. In addition, postprandial responses after maltodextrin intake were compared with a protein mix and sucrose. The ﬁrst study showed
signiﬁcantly lower fasting ED Z-scores and sICAM after 4 weeks on the high-protein diet (P≤ 0·02). The postprandial studies found no clear
differences of ED and LGI between test meals. However, postprandial sVCAM decreased more after the protein mix compared with
maltodextrin in both studies (P≤ 0·04). In conclusion, dietary protein is beneﬁcial for fasting ED, but not for fasting LGI, after 4 weeks of
supplementation. On the basis of Z-scores, postprandial ED and LGI were not differentially affected by protein sources or carbohydrates.
Key words: Proteins: Carbohydrates: Endothelial function: Inﬂammation: (Pre)hypertension
Consumption of dietary proteins at the expense of carbohydrates
lowers blood pressure(1,2), and mechanisms through which
proteins affect blood pressure need to be clariﬁed. Endothelial
dysfunction (ED) and low-grade inﬂammation (LGI) are
important factors in the progression of CVD(3,4), and they are
associated with hypertension(4,5). Both macronutrient and
micronutrient intake have been found to affect the levels of
biomarkers of ED and LGI(6,7). However, thus far, no clear
effects of long-term increased protein intake on levels of
C-reactive protein (CRP)(8–12), IL-6, TNFα(8–11), soluble E-selectin
(sE-selectin), soluble intercellular adhesion molecule 1 (sICAM)
and soluble vascular cell adhesion molecule 1 (sVCAM)(9,10) have
been found.
Although the effects of high-energy high-fat meals on post-
prandial levels of markers of ED and LGI have been studied
frequently(13–15), effects of protein and carbohydrate intake on
postprandial changes in markers of ED and LGI have been
investigated less often. In healthy volunteers, glucose intake
was found to increase sICAM, sVCAM, sE-selectin, IL-6 and CRP
postprandially compared with fasting values(16). Others found
* Corresponding author: M. A. van Baak, fax +31 43 36 70 976, email m.vanbaak@maastrichtuniversity.nl
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no effect of carbohydrate intake on postprandial levels of
sICAM, sVCAM, IL-6(17,18), CRP and sE-selectin(18). With regard
to dietary proteins, postprandial responses of markers of ED
and LGI to protein intake did not differ from those after
carbohydrate intake(19) or placebo(10).
We previously reported a blood-pressure-lowering effect
after a 4-week consumption of a protein mix compared with
maltodextrin in the randomised clinical trial on the effects of
PROteins on blood PRESsure (PROPRES)(20). The present
study aimed to explore chronic and postprandial effects of
protein intake compared with carbohydrate intake on ED and
LGI. We hypothesised that fasting levels of markers of ED and
LGI would be lower after 4 weeks on the high-protein diet
compared with the high-maltodextrin diet in the PROPRES
study and thus might contribute to the lower blood pressure
reported earlier(20). To determine whether possible chronic
effects of dietary protein on ED and LGI can also be observed
acutely, we compared postprandial levels of markers of ED and
LGI after ingestion of protein- and maltodextrin-supplemented
meals on the ﬁrst and last day of the intervention in the
PROPRES trial. A second postprandial study was conducted to
investigate whether different types of proteins or carbohydrates




The ﬁrst study was conducted in the year 2009 in a subset of the
study participants of the PROPRES study (n 52)(21), and it
consisted of a chronic, 4-week intervention, and postprandial
studies with postprandial assessments on the ﬁrst and last day of
the intervention (online Supplementary Fig. S1). Participants in
the chronic and postprandial parts of the PROPRES study were
overweight and obese individuals with untreated elevated
blood pressure (systolic blood pressure of 130–159 mmHg and/
or diastolic blood pressure of 85–99mmHg). More information
of inclusion and exclusion criteria are described elsewhere(20).
The second study was conducted in the year 2011, and it
consisted of a crossover evaluation of postprandial effects of
dietary proteins and carbohydrates. Participants had similar
characteristics as in the ﬁrst study, and part of this study group
had also participated in the PROPRES study(22). Both the ﬁrst
and second studies were conducted according to the guidelines
laid down in the Declaration of Helsinki, and all procedures
involving human subjects were approved by the medical-ethical
committee of Maastricht University Medical Center and
Maastricht University (METC azM/UM). Written informed con-
sent was obtained from all participants.
Chronic study
The chronic part of the PROPRES trial had a randomised parallel
group design and compared the effects of 4 weeks of exchan-
ging 3× 20 g/d of dietary carbohydrates isoenergetically with a
protein mixture (20 % pea protein, 20 % soya protein, 30 % egg-
white protein, 30 % milk protein isolates) or with maltodextrin
on ED and LGI. More details on the 4-week PROPRES trial can
be found elsewhere(20).
First postprandial study
This study was also part of the PROPRES trial. Twelve-hour
postprandial responses to standard mixed meals iso-
energetically supplemented with 20 g of the protein mixture or
with 20 g of maltodextrin were compared during a 12 h test day
at the start and a 12 h test day at the end of the 4-week
PROPRES trial. More details on the postprandial part of the
PROPRES study can be found elsewhere(21).
Second postprandial study
The 4 h postprandial responses after single ingestion of three
types of protein (pea, milk and egg-white protein isolate) and
two types of carbohydrate (maltodextrin and sucrose) and the
protein mix used in the PROPRES study were assessed in forty-
eight overweight participants with untreated elevated blood
pressure in the morning after an overnight fast. The six test
meals in this study contained 0·6 g/kg body mass of one of the
test products. Products were tested in a randomised order
crossover design (online Supplementary Fig. S2). Comparisons
were made between the three protein sources, and responses to
the ingestion of maltodextrin were compared with those after
the ingestion of sucrose and those after the protein mix. More
details of this study are described elsewhere(22).
Measurements
Because of their relationship with the risk for CVD(23) and their
responsiveness to nutritional interventions(24), von Willebrand
factor (vWf), sE-selectin, sICAM, sVCAM, CRP and serum amy-
loid A (SAA) were chosen as markers of ED (vWf, sE-selectin,
sICAM and sVCAM) and LGI (CRP, SAA and sICAM) in these
studies.
Chronic study. Venous blood for measurement of markers of
ED and LGI was collected before breakfast in the fasting state
on the ﬁrst and last days of the 4-week intervention.
First postprandial study. Postprandial measurements of vWf
and sE-selectin were taken at 1, 2 and 4 h after the protein- or
maltodextrin-supplemented breakfast (Fig. 1(a)). sICAM,
sVCAM, CRP and SAA were measured every 30min for the ﬁrst
2 h after breakfast (30, 60, 90, 120 min) and then hourly for the
following 10 h (3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 h) (Fig. 1(a)).
Lunch and dinner were consumed 4 and 8 h after breakfast,
respectively. These meals were also supplemented with the
protein mix or maltodextrin. More details of the meals are
described elsewhere(21).
Second postprandial study. All markers were measured in the
fasting state and hourly during 4 h after the test meal (60, 120, 180
and 240min) (Fig. 1(b)).
Plasma sICAM, sVCAM, sE-selectin, CRP and SAA were asses-
sed using a multi-array detection system based on
electro-chemiluminescence technology (SECTOR Imager 2400;
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Meso Scale Discovery), as previously described(25). vWf was
assessed in citrated plasma by means of an ELISA(25).
Statistical analyses
In addition to responses of individual biomarkers, overall
Z-scores for ED and LGI were also analysed to cope with
biological variability of each individual marker(25) and to ease the
interpretation of ﬁndings for individual biomarkers. To calculate
ED and LGI Z-scores, ﬁrst a Z was calculated for each individual
biomarker as follows: Z= (individual value−population mean)/
population SD. Individual biomarker Z-scores were averaged into
the overall Z-scores for ED and LGI. The overall ED Z-scores
consisted of the biomarkers sICAM, sVCAM, sE-selectin and vWf.
Overall LGI Z-scores consisted of CRP, SAA and sICAM. Overall
ED Z-scores for the 12 h test day only included sICAM and
sVCAM, because the other markers were not determined after
lunch until the end of the test day. Further explanations on the
calculation of overall Z-scores can be found elsewhere(25). The
population mean and population standard deviation for each
individual biomarker were calculated as follows in the different
studies: for the chronic study the population mean (and standard
deviation) was based on the average of the fasting levels on the
ﬁrst and last day of the intervention. For the ﬁrst postprandial
study, the population mean (and standard deviation) was based
on the average of all measurements during one test day. For the
second postprandial study, the population mean (and standard
deviation) was based on the average of all measurements during
all test days, because this was a crossover trial.
All statistical analyses were performed with the SPSS software
(version 20; IBM). A P value of <0·05 was considered to be
signiﬁcant. CRP and SAA were ln-transformed because of their
skewed distributions. Participants with CRP values >10mg/l
were excluded from analyses, because a CRP value this high
indicates the presence of inﬂammation(26), which could con-
found the postprandial responses.
Chronic study. Differences in fasting values between groups
on day 1 of supplementation were tested with an independent
samples t test. Fasting values after 4 weeks were tested with a
univariate ANCOVA with the fasting value on day 1 as a
covariate.
First postprandial study. Postprandial data on each test day
were analysed by a linear mixed model analysis using a random
intercept model. Analyses started off with the full model
including group, time, fasting measurement, BMI, age and sex.
BMI, age and sex were removed from the model one-by-one
starting with the least signiﬁcant covariate to test whether they
signiﬁcantly contributed to the model with a −2 log-likelihood
test. Signiﬁcant covariates were kept in the ﬁnal model. Incre-
mental AUC (iAUC) were calculated in the PROPRES study and
tested for deviance from 0 with a one-sample t test to see
whether postprandial increases/decreases were signiﬁcant.
Second postprandial study. Postprandial responses were
analysed with a linear mixed model approach that took the
crossover design and the correlation between repeated mea-
sures into account. The basic model consisted of a random
intercept at the individual level. If signiﬁcant, this model was
extended with a random intercept at the meal within individual
level (individual×meal) or with a serial correlation over time.
The basic model always included the following variables: time,
meal, fasting measurements and two variables controlling for
the crossover design – meal order and test day number. The
interaction term between meal and time (meal× time) and the
covariates age, sex and BMI were kept in the model if sig-
niﬁcant. In case of signiﬁcant meal× time or meal effect, ﬁve
post hoc comparisons were made – that is, maltodextrin v.
sucrose, maltodextrin v. protein mix, pea protein v. milk pro-
tein, pea protein v. egg-white protein and milk protein v. egg-
white protein. The critical P value was corrected for these
comparisons; therefore, post hoc differences were considered
signiﬁcant at P≤ 0·01(22).
Results
From the ﬁfty-two participants in the chronic study and ﬁrst
postprandial study (maltodextrin group n 27, protein group
n 25), three participants in the maltodextrin group were
excluded from the present analyses (online Supplementary
Fig. S1). This was because two participants had CRP values
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Fig. 1. Measurements on the test days in the first postprandial study (a) and
second postprandial study (b). Thick vertical lines represent measurements of
parameters mentioned in the same row. CRP, C-reactive protein; PROPRES,
randomised clinical trial on the effects of PROteins on blood PRESsure; SAA,
serum amyloid A; sE-selectin, soluble endothelial selectin; sICAM, soluble
intercellular adhesion molecule 1; sVCAM, soluble vascular cell adhesion
molecule 1; vWf, von Willebrand factor.
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missing fasting values on one test day. In the second post-
prandial study, product test days were excluded from analyses
when a participant had CRP levels >10mg/l during that particular
day. As a consequence, one test of sucrose, two tests of pea
protein, two tests of milk protein, two tests of egg-white protein
and three tests of the protein mix were excluded from analyses
(online Supplementary Fig. S2). Baseline characteristics of parti-
cipants in the ﬁrst postprandial study and the second postprandial
study have been published previously(21,22).
Chronic study: effects of the 4 weeks increased
protein intake on endothelial dysfunction and
low-grade inﬂammation
ED Z-scores, sICAM and sE-selectin were signiﬁcantly lower in
the protein group at the start of the intervention (P≤ 0·04,
Table 1), whereas only baseline-corrected ED Z-scores and
sICAM were signiﬁcantly lower in the protein group after
4 weeks of supplementation (P≤ 0·02, Table 1).
First postprandial study: postprandial responses
of endothelial dysfunction to protein- and
maltodextrin-supplemented meals
Analyses of iAUC showed signiﬁcant postprandial decreases on
the ﬁrst day of supplementation and after 4 weeks of supple-
mentation for ED Z-scores, sICAM, sVCAM and sE-selectin
(P≤ 0·05). Postprandial vWf decreased below fasting values on
day 1 of supplementation (P≤ 0·05), but not after 4 weeks.
Twelve-hour postprandial levels of ED Z-scores (composed
of sICAM and sVCAM) and sICAM tended to be lower after
ingestion of the protein-supplemented meals than after
ingestion of the maltodextrin-supplemented meals on day 1
(P= 0·07, 0·08, respectively; Fig. 2(a) and (c)), but these did not
differ signiﬁcantly after 4 weeks (Fig. 2(b) and (d)). Postprandial
sVCAM levels were signiﬁcantly lower after ingestion of the
protein-supplemented meals compared with the maltodextrin-
supplemented meals after 4 weeks of supplementation
(P= 0·04, Fig. 2(f)), but not on the ﬁrst day of supplementation
(Fig. 2(e)). Four-hour postprandial responses of ED Z-scores
(composed of sICAM, sVCAM, sE-selectin and vWf), sE-selectin
and vWf did not differ between protein- and maltodextrin-
supplemented meals on both test days (data not shown).
First postprandial study: postprandial responses
of low-grade inﬂammation to protein- and
maltodextrin-supplemented meals
Analyses of iAUC revealed signiﬁcant postprandial decreases of
LGI Z-scores (composed of CRP, SAA and sICAM) on both test
days (iAUC P≤ 0·05, Fig. 3(a) and (b)), whereas postprandial
CRP levels increased signiﬁcantly on day 1 and postprandial
SAA levels decreased signiﬁcantly after 4 weeks (iAUC P≤ 0·05,
Fig. 3(c) and (f), respectively). Postprandial responses of LGI
Z-scores, CRP and SAA did not differ between protein- and
maltodextrin-supplemented meals (Fig. 3(a)–(f)).
Second postprandial study: postprandial responses of
endothelial dysfunction after consumption of various
protein and carbohydrate sources
Postprandial levels of ED Z-scores did not differ between pro-
tein sources or between maltodextrin v. sucrose or maltodextrin v.
protein mix (Fig. 4(a) and (b)). Pea protein consumption induced
lower postprandial levels of sICAM compared with egg-white
protein consumption (P≤ 0·001). Ingestion of the protein
mix resulted in lower postprandial levels of sICAM and
sVCAM compared with ingestion of maltodextrin (P≤ 0·004,
Fig. 4(c)–(f)). Postprandial responses of sE-selectin and vWf did
not differ between test meals (Fig. 4(g)–(j)).
Second postprandial study: postprandial responses
of LGI after consumption of various protein and
carbohydrate sources
Postprandial responses in LGI Z-scores did not differ between
protein sources or between maltodextrin and sucrose or
maltodextrin and the protein mix (Fig. 5(a) and (b)). Ingestion
of pea protein induced higher postprandial SAA levels than
Table 1. Baseline and 4-week levels of markers of endothelial dysfunction (ED) and low-grade inflammation (LGI) in the chronic study
(Mean values with their standard errors)
Maltodextrin Protein
Day 1 4 weeks Day 1 4 weeks
Mean SEM Mean SEM n Mean SEM Mean SEM n
ED Z-score 0·30* 0·18 0·27† 0·15 21 −0·21* 0·12 −0·33† 0·10 22
LGI Z-score −0·01 0·15 0·24 0·16 24 −0·14 0·18 −0·08 0·14 25
sICAM (μg/l) 215* 8 224† 8 24 191* 7 182† 6 25
sVCAM (μg/l) 362 19 365 17 24 353 13 351 13 25
sE-selectin (μg/l) 100* 7 101 8 21 73* 7 69 6 22
vWf (%) 102 7 92 6 21 86 6 86 6 22
CRP (mg/l)‡ 1·79 0·35 2·29 0·45 24 1·51 0·30 1·50 0·20 25
SAA (mg/l)‡ 1·17 0·23 1·48 0·28 24 1·65 0·34 1·77 0·23 25
CRP, C-reactive protein; SAA, serum amyloid A; sE-selectin, soluble endothelial selectin; sICAM, soluble intercellular adhesion molecule 1; sVCAM, soluble vascular cell adhesion
molecule 1; vWf, von Willebrand factor.
* P< 0·05 for between-group differences on day 1 tested with an independent samples t test.
† P< 0·05 for between-group differences after 4 weeks tested with ANCOVA correcting for the fasting value on day 1.
‡ Statistical tests were performed with ln-transformed data.
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ingestion of milk and egg-white protein (P< 0·001, Fig. 5(e)
and (f)). Ingestion of the protein mix resulted in higher post-
prandial CRP levels than ingestion of maltodextrin (P< 0·001,
Fig. 5(c) and (d)).
Discussion
Chronic study
The most important ﬁndings in the studies reported here are the
lower fasting levels of ED Z-scores and sICAM after 4 weeks on
the protein diet compared with the maltodextrin diet in the
PROPRES study. Literature data on the effects of protein-
enriched diets on fasting levels of markers of ED are
relatively scarce. Two-week consumption of a novel whey-
derived peptide (5 g/d) did not affect fasting values of
sE-selectin, sICAM, sVCAM and CRP compared with placebo in
healthy individuals(10). Eight-week consumption of 40 g/d
soyabean protein (including isoﬂavones) lowered fasting levels
of sE-selectin compared with intake of 40 g/d milk protein, but
not compared with the intake of 40 g/d complex carbohydrate.
No differences between supplements were found for fasting
sICAM and sVCAM levels(9). In contrast to these two studies, we
demonstrated a decrease of sICAM levels after the protein mix.
One explanation for our ﬁnding could be the greater difference
in protein intake (60 g/d) between groups in our study. In
addition to soya and milk protein, our protein mix also
consisted of pea protein and egg-white protein. Therefore, our
results are consistent with the view that increased protein intake
improves markers of ED within 4 weeks under fasting condi-
tions. This may be related to the dose of protein and/or the mix
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Fig. 2. 12 h Postprandial responses of endothelium function to meals supplemented with protein or maltodextrin on day 1 of supplementation (left) and after 4 weeks of
supplementation (right) in the first postprandial study. (a, b) Endothelial dysfunction (ED) Z-scores, (c, d) soluble intercellular adhesion molecule 1 (sICAM) and (e, f)
soluble vascular cell adhesion molecule 1 (sVCAM). Participants included in analyses: maltodextrin group ( , n 24) and protein group ( , n 25). Vertical lines
indicate breakfast, lunch and dinner. Values are means with their standard errors. * P<0·05 for the difference between the maltodextrin group and the protein group
over the whole 12 h period according to the mixed model.
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Fasting levels of markers of LGI did not differ between the
protein and maltodextrin group after the 4-week intervention.
This is consistent with a 12 week trial, which found no differ-
ences in fasting concentrations of TNFα, IL-6 and CRP between
a whey-, casein- or glucose-supplemented diet (54 g/d)(11). In
another study, fasting CRP levels did not signiﬁcantly differ after
8 weeks of soyabean protein or milk protein consumption
compared with complex carbohydrate(9). Eight weeks on a
high-protein weight loss diet (30 % of energy intake) also
did not affect fasting CRP levels compared with a high-
carbohydrate/ﬁbre weight loss diet (20 % of energy intake from
protein)(12), nor did 1-week consumption of milk tripeptides v.
placebo(27). However, two other studies found unfavourable
effects of increased protein intake on LGI. The DIOGENES
randomised controlled trial, comparing diets with higher/
lower-protein content combined with higher/lower glycaemic
index, found evidence that the lower-protein diets were asso-
ciated with lower fasting CRP concentrations than the higher-
protein diets(28). A recent weight loss trial found increased
inﬂammation scores after a high-protein weight loss diet (30 %
of energy intake) compared with a normal-protein weight loss
diet (15 % of energy intake), whereas levels of individual
markers CRP, TNFα, plasminogen activator inhibitor-1 (PAI-1)
and IL-6 did not differ between groups. This increased inﬂam-
mation score was found especially for high animal and meat
protein intake and not for increased vegetable or ﬁsh protein
intake(8). The protein supplement in our study was only partly
composed of animal protein (60 %:30 % milk and 30 % egg-
white protein) and not in the form of meat protein, which may
explain why we did not ﬁnd increased LGI in the protein group.
In addition, the LGI Z-score in our study was composed of other
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Fig. 3. 12 h Postprandial responses of low-grade inflammation (LGI) to meals supplemented with protein or maltodextrin on day 1 of supplementation (left) and after
4 weeks of supplementation (right) in the first postprandial study. (a, b) LGI Z-scores, (c, d) C-reactive protein (CRP) and (e, f) serum amyloid A (SAA). Participants
included in analyses: maltodextrin group ( , n 24) and protein group ( , n 25). Vertical lines indicate breakfast, lunch and dinner. Values are means with their
standard errors. Postprandial responses did not differ between groups according to the mixed model.
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Fig. 4. 4 h Postprandial responses of endothelium function to different protein sources (left) and maltodextrin, sucrose and a protein mix (right) in the second
postprandial study. (a, b) Endothelial dysfunction (ED) Z-scores, (c, d) soluble intercellular adhesion molecule 1 (sICAM), (e, f) soluble vascular cell adhesion molecule
1 (sVCAM), (g, h) soluble endothelial selectin (sE-selectin) and (i, j) von Willebrand factor (vWf). Participants included in analyses: pea protein ( , n 45), milk
protein ( , n 46), egg-white protein ( , n 45), maltodextrin ( , n 47), sucrose ( , n 45) and protein mix ( , n 45).
Values are means with their standard errors. * Significant difference between protein mix and maltodextrin over the whole 4 h period shown by post hoc tests with
Bonferroni correction (P≤ 0·01) if the meal was significant (P≤ 0·05). † Significant difference between pea protein and egg-white protein over the whole 4 h period
shown by post hoc tests with Bonferroni correction (P≤ 0·01) if the meal was significant (P≤ 0·05).
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Thus, we may conclude that increased protein intake has no
effect on the levels of markers of LGI under fasting conditions,
which is in agreement with several studies(9,12,19,27) but con-
trasts with ﬁndings of two food-based interventions(8,28). This
may be related to differences in the type of proteins included in
the diets/supplements. Moreover, in food-based studies, the
effects of other food constituents cannot be fully excluded.
First and second postprandial studies
Postprandial sVCAM levels were found to be lower after
protein-supplemented meals compared with maltodextrin-
supplemented meals after 4 weeks of intervention in the ﬁrst
postprandial study and after consumption of 0·6 g/kg of the
protein mix compared with maltodextrin in the second
postprandial study. Glucose and insulin might be involved in
this difference. In a study investigating the effects of ingestion of
75 g glucose v. fructose, both carbohydrates induced similar 3 h
postprandial responses of sVCAM despite different postprandial
glucose and insulin responses(18), which suggests that glucose
and insulin do not modulate postprandial sVCAM levels. We
found that other markers of ED and the ED Z-scores did not
differ consistently between the protein mix and maltodextrin.
Taken together, we found no clear differences in postprandial
responses of ED between a protein mix and maltodextrin.
Postprandial CRP levels were found to be signiﬁcantly higher
after ingestion of the protein mix than after ingestion of mal-
todextrin in the second postprandial study. However, this differ-
ence is unlikely to be detrimental, as baseline CRP levels were
low and the difference in postprandial CRP was small. In addition,
postprandial levels of LGI Z-scores, SAA and sICAM did not differ
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Fig. 5. 4 h Postprandial responses of low-grade inflammation (LGI) to different protein sources (left) and maltodextrin, sucrose and a protein mix (right) in the second
postprandial study. (a, b) LGI Z-scores, (c, d) C-reactive protein (CRP) (e, f) and serum amyloid A (SAA). Participants included in analyses: pea protein ( , n 45),
milk protein ( , n 46), egg-white protein ( , n 45), maltodextrin ( , n 47), sucrose ( , n 45) and protein mix ( , n 45). Values are means with
their standard errors. * Significant difference between protein mix and maltodextrin over the whole 4 h period shown by post hoc tests with Bonferroni correction
(P≤ 0·01) if a meal was significant (P≤ 0·05). † Significant difference between pea protein and egg-white protein over the whole 4 h period shown by post hoc tests with
Bonferroni correction (P≤ 0·01) if meal was significant (P≤ 0·05). ‡ Significant difference between pea protein and milk protein over the whole 4 h period shown by post
hoc tests with Bonferroni correction (P≤ 0·01) if meal was significant (P≤0·05).
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addition, in our ﬁrst postprandial study, we did not ﬁnd signiﬁcant
differences in postprandial levels of LGI markers between the
protein- and maltodextrin-supplemented meals, which is in
accordance with another study comparing postprandial effects of
protein and carbohydrate-supplemented breakfasts(19). In con-
clusion, we found no clear evidence of differences in postprandial
LGI between a protein mix and maltodextrin.
Postprandial responses of markers of ED and LGI were also
compared between pea protein, milk protein and egg-white
protein ingestion in the second postprandial study. Postprandial
sICAM levels were lower after pea protein compared with egg-
white protein. The higher arginine content in pea protein (8·7/
100 g) compared with milk protein (3·7/100 g) and egg-white
protein (6/100 g) might be involved in this, as arginine has been
suggested to improve endothelial function because of its role in
nitric oxide synthesis(29). Addition of arginine to amino acid
meals(30) or high-fat meals(31) was shown not to affect post-
prandial levels of sICAM(30) or vWf(30,31). We found that pea
protein induced higher postprandial SAA levels compared with
egg-white protein and milk protein. Holmer-Jensen et al.(32)
also found differences in postprandial inﬂammation between
high-fat mixed meals supplemented with different protein
sources. Whey protein consumption, which was the most
insulinotropic protein source, resulted in lower postprandial CC
chemokine ligand-5 concentrations but the highest postprandial
levels of monocyte chemotactic protein 1. Both are markers of
inﬂammation, and the authors could not explain the opposing
effects of whey protein(32). In our study, the most insulinotropic
protein (pea protein(22)) also showed opposing effects on
postprandial responses of LGI markers (lower sICAM and
higher SAA levels) compared with the other protein sources.
Whether postprandial insulin levels have a role in postprandial
levels of sICAM and SAA remains unclear.
Some limitations need to be considered when interpreting
the results of the studies reported in this paper. One limitation
is that measurements discussed in this paper were not the
primary end points of these studies. Therefore, these studies
could be underpowered for ﬁnding signiﬁcant differences in
ED and LGI between groups. In addition, only few of the
currently available biomarkers of ED and LGI were measured
in these studies. Therefore, the effects of dietary proteins on
ED and LGI need to be explored further by studying other
biomarkers of ED and LGI in addition to the biomarkers mea-
sured in our studies such as endothelin-1, nitric oxide metabolites,
PG, TNFα and IL-6(3). Another limitation of our studies is the lack
of a functional measurement of ED, such as ﬂow-mediated dila-
tion (FMD). This was not manageable because of the large
number of measurements taken in both studies(21,22). However,
the addition of FMD does not improve the association of circu-
lating biomarkers with carotid arterial stiffening(33). Finally, the
role of isoﬂavones in the improvement of markers of ED in the
chronic study cannot be fully excluded(34), because isoﬂavones
could have been present in the soya protein isolate in the protein
mix. In conclusion, the present study found evidence that fasting
ED Z-scores and sICAM levels are lower after 4 weeks on an
increased protein diet compared with an increased maltodextrin
diet, whereas fasting levels of biomarkers of LGI do not differ.
Both of our postprandial studies indicate no clear evidence of a
favourable effect of protein intake compared with maltodextrin
intake on postprandial responses of ED and LGI. Postprandial
responses of some biomarkers of ED and LGI differed between
protein sources, but the importance of these differences is not
clear, because overall ED and LGI Z-scores did not differ between
protein sources. Postprandial responses of ED and LGI to the
ingestion of maltodextrin did not differ from those after the
ingestion of sucrose.
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